comparemela.com

Latest Breaking News On - Clabsi - Page 1 : comparemela.com

Revolutionary UV-C Device Offers Hope in the Fight Against Central Line-associated Bloodstream Infections (CLABSIs)

A recent study’s results demonstrate that PuraCath Medical Inc.'s breakthrough UV-C device disinfects needleless connectors, potentially reducing CLABSI risks in hospital settings.

Austin s Post-Op Infection Highlights Lag In CDC s Overall Prevention Effort

Reducing CLABSIs by 47%: The Impact of Trained Nurse Observers in Catheter Insertion Teams

A recent study from Chapel Hill, NC, shows some bloodstream infections are reduced by nearly 50% when trained nurse observers assist catheter insertion teams.

Hospitals have ways to go on HAIs

Data from The Leapfrog Group shows hospitals have made progress reversing a major spike in healthcare-associated infections, however, there is still work to be

Access Vascular secures $22M funding for biocompatible catheters

Access Vascular Inc. (AVI) closed a $22 million series C funding round that it plans to use principally to increase production capacity for its Mimix hydrophilic biomaterial vascular access devices. The company’s catheters are designed to evade identification as foreign bodies, reduce bacterial adhesion and eliminate catheter-related thrombus development.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.